Related Experiment Video
Updated: Aug 12, 2026
08:02
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Hyperbaric hyperoxia exaggerates respiratory membrane defects in the copper-deficient rat lung
1Department of Physiology, School of Medicine, University of North Dakota, Grand Forks 58202.
Biological Trace Element Research
|August 1, 1993
Summary
Dietary copper deficiency worsens lung damage from oxygen toxicity. Copper deficiency alone thickened lung membranes, while combined deficiency and oxygen exposure severely damaged lung structure, possibly due to reduced antioxidant defenses.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Nutritional Science
Background:
- Dietary copper is essential for lung health and antioxidant function.
- Hyperbaric hyperoxia (high oxygen pressure) can cause lung injury.
- The combined effects of copper deficiency and hyperbaric hyperoxia on lung structure are not well understood.
Purpose of the Study:
- To investigate the impact of dietary copper deficiency and hyperbaric hyperoxia, individually and combined, on rat lung morphology.
- To elucidate the cellular and structural changes in the lungs under these conditions.
Main Methods:
- Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were utilized.
- Rats were fed either a copper-deficient or copper-adequate diet.
- Animals were exposed to either normal air or hyperbaric hyperoxia.
Main Results:
- Copper deficiency alone led to thicker respiratory membranes and abnormal red blood cells.
- Hyperbaric hyperoxia exposure in copper-adequate rats caused thicker respiratory membranes and increased surfactant vacuoles.
- Combined copper deficiency and hyperbaric hyperoxia resulted in severely thickened respiratory membranes, disrupted endothelium and basement membranes, and increased cell numbers.
Conclusions:
- Copper deficiency exacerbates lung damage induced by oxygen toxicity.
- Reduced antioxidant status secondary to copper deficiency may contribute to this enhanced susceptibility to oxygen-induced lung injury.
Related Concept Videos
01:27Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.